A series of new HIV-1 protease inhibitors with the hydroxyethylamine core and different hydroxyprolinamide P2 ligands were designed and synthesized. Variation of substitutions at the P2 significantly affected the enzyme inhibitory potency of the inhibitors. Compounds 2a and 2d showed excellent enzyme inhibitory activity with IC 50 values in the nanomolar range. An active site binding model for inhibitors 2a and 2d was suggested based upon the computational-docking results of the ligand with HIV-1 protease. This model offers molecular insights regarding ligand-binding site interactions of the hydroxyprolinamide-derived novel P2-ligand. © 2011 Elsevier Ltd. All rights reserved.
CITATION STYLE
Gao, B. L., Zhang, C. M., Yin, Y. Z., Tang, L. Q., & Liu, Z. P. (2011). Design and synthesis of potent HIV-1 protease inhibitors incorporating hydroxyprolinamides as novel P2 ligands. Bioorganic and Medicinal Chemistry Letters, 21(12), 3730–3733. https://doi.org/10.1016/j.bmcl.2011.04.070
Mendeley helps you to discover research relevant for your work.